ABSTRACT
In recent years, due to the impact of COVID-19 around the world, there has been a serious shortage of medical resources. In order to supplement the manpower and fear that medical staff's contact with patients will cause a breach in the epidemic, reduce the workload of nurses, and help nurses perform repetitive tasks so that nurses can concentrate more on the patient's condition. Therefore, this paper proposes M-Robot, which is a friendly interface service robot based on the Android system and can be controlled by voice, touch, and remote control in the medical care field. The system is mainly divided into two parts. One is the web server. The web server is divided into two parts: front-end and back-end. The front-end is responsible for friendly user interface management, and the back-end is for accessing the SQLite database, as well as processing speech recognition and semantic understanding in voice services. In the other part, we use TEMI robot to develop and complete the desired service. Its service content includes environment introduction, delivery service, questionnaire survey, broadcast car, scheduling reminder, follow-up record, and patient instruction video. In the voice control mode, the user can say the wake-up word to the robot and say the required service content, and the robot will execute after receiving the message;in the remote control mode, we provide a friendly web interface for remote control. As well as the information needed to manage various services. © 2022 IEEE.
ABSTRACT
Case Report With the execution of expanded newborn screen (NBS) program nationwide, it is uncommon to see severe hyperammonemia associated with IVA. We present a sevenday- old boy with severe IVA complicated with hyperammonemia. This child was flagged by NBS at day 4, but due to COVID19 and parental skepticism, confirmatory testing was delayed and a leu restricted diet was not followed as instructed. The patient initially presented to the ED with Ammonia of 588 ug/dL which then increased to 1000 ug/dL. This child received carnitine, arginine, carglumic acid (Carbaglu), CRRT, and Ammonul. The Ammonul was not helpful. Ammonul has two major components sodium benzoate and sodium phenylacetate. Sodium benzoate functions by removing glycine with ammonia which could be harmful for this condition as IVA needs to bind to glycine as a rescue. Sodium phenylacetate binds to glutamine to remove ammonia but this patient's plasma amino acid assay revealed a low glutamine level of 256 umol/L. The hyperammonemia was corrected in 15 hours, and with the use of Carbaglu there was no rebound of hyperammonemia. Our patient suffered from bone marrow suppression associated to the organic acidemia and required frequent multiple platelet transfusions and GCSF for neutropenia. The management of this patient provides supporting evidence of the many theoretic metabolic 'facts' including why Ammonul is not helpful in organic acidemias.